Mesoblast
MESO
33 hedge funds and large institutions have $4.42M invested in Mesoblast in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 7 closing their positions.
87% more call options, than puts
Call options by funds: $1.12M | Put options by funds: $599K
0.01% more ownership
Funds ownership: 0.24% → 0.25% (+0.01%)
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
11% less funds holding
Funds holding: 37 → 33 (-4)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
43% less capital invested
Capital invested by funds: $7.81M → $4.42M (-$3.39M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$292K |
| 2 |
Morgan Stanley
New York
|
+$133K |
| 3 |
Millennium Management
New York
|
+$83.7K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$52K |
| 5 |
MFG
Merit Financial Group
Alpharetta,
Georgia
|
+$41.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$52K |
| 2 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$46K |
| 3 |
HWAM
Hennion & Walsh Asset Management
Parsippany,
New Jersey
|
-$41.2K |
| 4 |
CG
Cutler Group
San Francisco,
California
|
-$5.29K |
| 5 |
LC
Lindbrook Capital
Calabasas,
California
|
-$4.98K |
MESO Hedge Fund Activity: Q2 2022 in Review
33 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q2 2022, worth a combined $4.42M — down 43% from $7.81M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of MESO and 4 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 7 added.
The largest buyer was Susquehanna International Group, adding an estimated $292K. The largest seller was BlackRock, cutting an estimated $52K.
- 33 institutional investors held Mesoblast (MESO) as of Q2 2022, down from 37 in Q1 2022.
- Funds reported $4.42M of Mesoblast stock for Q2 2022, down 43% quarter-over-quarter.
- 4 funds opened new Mesoblast positions in Q2 2022 and 7 closed out, a net change of -3 holders.
- The largest Mesoblast buyer in Q2 2022 was Susquehanna International Group, an estimated $292K added.
- The largest Mesoblast seller in Q2 2022 was BlackRock, an estimated $52K sold.
Based on aggregated 13F filings for Q2 2022.